Research map: Patient-reported outcomes in Chinese patients with AQP4-IgG–positive neuromyelitis optica spectrum disorder on inebilizumab therapy: a cross-sectional study

Back to the article

Papers in this map

  1. The MOS 36-ltem Short-Form Health Survey (SF-36) · John E. Ware · 1992 · 30244 citations · Cited by this paper
  2. Ethnic and racial characteristics of hemifacial spasm in Hawaii: a clinical cohort analysis · 2026 · Related
  3. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders · Dean M. Wingerchuk · 2015 · 4672 citations · Cited by this paper
  4. Infarct growth rate modifies treatment benefit in anterior circulation large vessel occlusion stroke: direct thrombectomy or bridging therapy · 2026 · Related
  5. Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial · Bruce Cree · 2019 · 744 citations · Cited by this paper
  6. Clinical, neuropsychological and radiological features in influenza virus-associated encephalitis: a case series · 2026 · Related
  7. Neuromyelitis optica spectrum disorders: from pathophysiology to therapeutic strategies · Edgar Carnero Contentti · 2021 · 342 citations · Cited by this paper
  8. Effect of inspiratory muscle training on trunk control in patients with stroke: a systematic review of randomized controlled trials · 2026 · Related
  9. Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders · Valentina Damato · 2016 · 293 citations · Cited by this paper
  10. Association between PCSK9 and post-stroke cognitive impairment: a retrospective cohort study and predictive models establishment based on machine learning · 2026 · Related
  11. Epidemiology of Neuromyelitis Optica in the United States · Maureen A. Mealy · 2012 · 288 citations · Cited by this paper
  12. Association of high-sensitivity C-reactive protein-triglyceride glucose index and stroke outcomes: results from the China National Stroke Registry III · 2026 · Related
  13. Comparison of the efficacy of azathioprine and rituximab in neuromyelitis optica spectrum disorder: a randomized clinical trial · Zahra Nikoo · 2017 · 194 citations · Cited by this paper
  14. Stereotactic radiosurgery for post-herpetic trigeminal neuralgia: results of a case-control study · 2026 · Related
  15. New therapies for neuromyelitis optica spectrum disorder · Michael Levy · 2020 · 152 citations · Cited by this paper
  16. Risk factors of recurrent hemorrhage following minimally invasive transcranial puncture and drainage in patients with spontaneous intracerebral hemorrhage: a retrospective cohort study · 2026 · Related
  17. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial · Bruce Cree · 2024 · 67 citations · Cited by this paper
  18. Belumosudil-associated neurological adverse events: evidence from FAERS and experimental validation · 2026 · Related
  19. Aquaporin‐4 Antibody Dynamics and Relapse Risk in Seropositive Neuromyelitis Optica Spectrum Disorder Treated with Immunosuppressants · Hexiang Yin · 2023 · 36 citations · Cited by this paper
  20. Long-Term Effectiveness and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder: A 5-Year Observational Study · Giovanni Novi · 2025 · 9 citations · Cited by this paper
  21. Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments · Philippe‐Antoine Bilodeau · 2026 · 8 citations · Cited by this paper
  22. Efficacy and Safety of Rituximab Versus Inebilizumab in Patients With Neuromyelitis Optica Spectrum Disorder: A Dual‐Center, Real‐World Cohort Study · Ying Cui · 2026 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)